FIKCX
Price
$72.89
Change
+$1.24 (+1.73%)
Updated
Jul 2 closing price
Net Assets
3.17B
VHCIX
Price
$154.38
Change
+$3.94 (+2.62%)
Updated
Jul 2 closing price
Net Assets
18.99B
Interact to see
Advertisement

FIKCX vs VHCIX

FIKCX vs VHCIX Comparison Chart in %
View a ticker or compare two or three
VS
FIKCX vs. VHCIX commentary
Jul 06, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FIKCX is a Buy and VHCIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VHCIX has more cash in the bank: 19B vs. FIKCX (3.17B). VHCIX pays higher dividends than FIKCX: VHCIX (1.58) vs FIKCX (0.00). FIKCX was incepted earlier than VHCIX: FIKCX (8 years) vs VHCIX (22 years). FIKCX (0.56) is less costly to investors than VHCIX (0.09). FIKCX is a more actively managed with annual turnover of: 52.00 vs. VHCIX (4.00). FIKCX has a lower initial minimum investment than VHCIX: FIKCX (0) vs VHCIX (100000). VHCIX annual gain was more profitable for investors over the last year : 24.11 vs. FIKCX (19.85). VHCIX return over 5 years is better than : 23.67 vs. FIKCX (-5.37).
FIKCXVHCIXFIKCX / VHCIX
Total Expense Ratio0.560.09622%
Annual Report Gross Expense Ratio0.560.09622%
Fund Existence8 years22 years-
Gain YTD12.1217.376164%
Front LoadN/AN/A-
Min. Initial Investment0100000-
Min. Initial Investment IRAN/AN/A-
Net Assets3.17B19B17%
Annual Yield % from dividends0.001.58-
Returns for 1 year19.8524.1182%
Returns for 3 years11.1527.6240%
Returns for 5 years-5.3723.67-23%
Returns for 10 yearsN/A136.15-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GSIWX35.490.47
+1.34%
Goldman Sachs International Eq ESG R6
GRETX9.360.12
+1.30%
Goldman Sachs Real Estate Securities Inv
VLAIX34.120.37
+1.10%
Value Line Asset Allocation Instl
VSEQX44.87-0.18
-0.40%
Vanguard Strategic Equity Inv
JGRQX21.79-0.25
-1.13%
JPMorgan Small Cap Growth R3